Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders
Neelam Varma(Nagpur Institute of Technology), Subhash Varma(Post Graduate Institute of Medical Education and Research), Raju Poongodi(Mackay Memorial Hospital), Shano Naseem(Post Graduate Institute of Medical Education and Research), Parveen Bose(Post Graduate Institute of Medical Education and Research)
Cited by 8
Related Papers
X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene
|The American Journal of Human Genetics|1999|264
Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis – Case report and systematic review
|Journal of Infection|2008|114
Imatinib has adverse effect on growth in children with chronic myeloid leukemia
|Pediatric Blood & Cancer|2011|95
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axis
|Pediatric Blood & Cancer|2013|85